###begin article-title 0
Control of Muscle Mitochondria by Insulin Entails Activation of Akt2-mtNOS Pathway: Implications for the Metabolic Syndrome
###end article-title 0
###begin p 1
Conceived and designed the experiments: JP SH JP DC MC. Performed the experiments: PF FB SH MF CM DC. Analyzed the data: JP PF JP CM AE MC. Contributed reagents/materials/analysis tools: AE. Wrote the paper: JP MC.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 398 401 398 401 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">via</italic>
###xml 463 464 463 464 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 470 471 470 471 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
In the metabolic syndrome with hyperinsulinemia, mitochondrial inhibition facilitates muscle fat and glycogen accumulation and accelerates its progression. In the last decade, nitric oxide (NO) emerged as a typical mitochondrial modulator by reversibly inhibiting citochrome oxidase and oxygen utilization. We wondered whether insulin-operated signaling pathways modulate mitochondrial respiration via NO, to alternatively release complete glucose oxidation to CO2 and H2O or to drive glucose storage to glycogen.
###end p 3
###begin title 4
Methodology/Principal Findings
###end title 4
###begin p 5
###xml 449 456 449 456 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in situ</italic>
###xml 530 531 530 531 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 634 635 634 635 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 652 659 652 659 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 902 904 902 904 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">14</sup>
###xml 1018 1019 1010 1011 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1062 1063 1046 1047 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 1064 1065 1048 1049 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1079 1080 1063 1064 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 247 251 <span type="species:ncbi:10116">rats</span>
###xml 270 275 <span type="species:ncbi:9606">human</span>
We illustrate here that NO produced by translocated nNOS (mtNOS) is the insulin-signaling molecule that controls mitochondrial oxygen utilization. We evoke a hyperinsulinemic-normoglycemic non-invasive clamp by subcutaneously injecting adult male rats with long-lasting human insulin glargine that remains stable in plasma by several hours. At a precise concentration, insulin increased phospho-Akt2 that translocates to mitochondria and determines in situ phosphorylation and substantial cooperative mtNOS activation (+4-8 fold, P<.05), high NO, and a lowering of mitochondrial oxygen uptake and resting metabolic rate (-25 to -60%, P<.05). Comparing in vivo insulin metabolic effects on gastrocnemius muscles by direct electroporation of siRNA nNOS or empty vector in the two legs of the same animal, confirmed that in the silenced muscles disrupted mtNOS allows higher oxygen uptake and complete (U-14C)-glucose utilization respect to normal mtNOS in the vector-treated ones (respectively 37+/-3 vs 10+/-1 micromolO2/h.g tissue and 13+/-1 vs 7.2+/-1 micromol 3H2O/h.g tissue, P<.05), which reciprocally restricted glycogen-synthesis by a half.
###end p 5
###begin title 6
Conclusions/Significance
###end title 6
###begin p 7
###xml 117 120 117 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">via</italic>
These evidences show that after energy replenishment, insulin depresses mitochondrial respiration in skeletal muscle via NO which permits substrates to be deposited as macromolecules; at discrete hyperinsulinemia, persistent mtNOS activation could contribute to mitochondrial dysfunction with insulin resistance and obesity and therefore, to the progression of the metabolic syndrome.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 235 238 235 238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001749-Trimmer1">[1]</xref>
###xml 239 242 239 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001749-Boveris1">[2]</xref>
###xml 543 546 543 546 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001749-Auwerx1">[3]</xref>
###xml 647 650 647 650 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001749-Houstis1">[4]</xref>
###xml 937 942 937 942 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 1175 1178 1175 1178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001749-Petersen1">[5]</xref>
###xml 1258 1261 1258 1261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001749-Derave1">[6]</xref>
The powerhouse of the cell, mitochondria are responsible for sustaining energy levels. However, a number of the new functions discovered for mitochondria in the past decade depend not on energy demand but on adjustments to respiration [1]-[2]. Critical reduction of respiration takes part as well in the mechanisms of prevalent illnesses; a reduction of mitochondrial activity and the decrease in energy expenditure contribute substantially to metabolic dysfunction in aging, insulin resistance and diabetes and conducts to lipid accumulation [3]. Of the many studies focused on insulin resistance and mitochondrial dysfunction in the last decade [4], few have critically examined mitochondrial activity in terms of alternation between complete substrate oxidation and storage as macromolecular deposits [glycogen or fat stores]. A mutual connection between decreased respiratory rate and the synthesis pathways was reported by Petersen et al who found that 40% reduction in mitochondrial oxidative and phosphorylation activity increased intramyocellular lipid content in elderly volunteers with severe muscle insulin resistance, compared with matched young control subjects [5]. Although lipid and glycogen accumulation further increases insulin resistance [6], a clear mechanism for reduction of mitochondrial oxidations with displacement of substrates to storage was not defined in this context yet.
###end p 9
###begin p 10
###xml 24 25 24 25 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 38 39 38 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</italic>
###xml 287 290 287 290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001749-Carreras1">[7]</xref>
###xml 473 480 473 480 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 542 543 542 543 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 550 553 550 553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001749-Poderoso1">[8]</xref>
With high affinity for O2, cytochrome c oxidase is responsible for the final transference of electrons to oxygen for reduction to water in mitochondria. In the last years, cumulative evidence shows that mitochondrial NO is a typical regulator that binds cytochrome oxidase at subunit II [7], competes with high-affinity for oxygen occupancy, and thus reversibly inhibits cytochrome oxidase and reduces respiration at nanomolar concentrations; at equal demands, physiologic in vivo oxygen utilization by mitochondria depends on the matrix NO/O2 ratio [8].
###end p 10
###begin p 11
###xml 105 107 105 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in</italic>
###xml 113 116 113 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001749-Brown1">[9]</xref>
###xml 233 237 233 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001749-Giulivi1">[10]</xref>
###xml 370 374 366 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001749-Franco1">[11]</xref>
###xml 382 386 378 382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001749-Persichini1">[12]</xref>
###xml 506 510 498 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001749-Kanai1">[13]</xref>
###xml 681 685 673 677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001749-Peralta1">[14]</xref>
###xml 686 690 678 682 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001749-Zaobornyj1">[16]</xref>
###xml 862 866 854 858 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001749-Brookes1">[17]</xref>
###xml 1133 1137 1125 1129 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1412</sup>
###xml 1133 1137 1125 1129 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>1412</sup></bold>
###xml 1319 1320 1311 1312 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</italic>
###xml 1548 1552 1540 1544 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001749-Cho1">[18]</xref>
###xml 618 621 <span type="species:ncbi:10116">rat</span>
###xml 1058 1061 <span type="species:ncbi:10116">rat</span>
Although the diffusible NO yielded by cytosol nitric oxide synthase (NOS) isoforms modulates respiration in vivo [9], an advantage comes from the mitochondrial compartmentalization of NOS (mitochondrial nitric oxide synthase; mtNOS) [10] that directs NO flux vectorially to the matrical space. In particular, neuronal nitric oxide synthase [nNOSalpha] binds complexes I [11] and IV [12] through specific domains; most of the mitochondrial NO yield is abolished by targeted disruption of the nNOSalpha gene [13]. Likewise, activation of mtNOS and enhanced mitochondrial NO levels were previously demonstrated in normal rat development, hypothyroidism, cold acclimation, and hypoxia [14]-[16]. At reduced mitochondrial respiratory activity, mtNOS modulation should therefore be equally important for insulin effects. Matrix NO reduces oxygen uptake and ATP levels [17], thereby increasing the level of reduced equivalents and acetyl-S-coenzyme A (acetyl-CoA), the substrates for anaplerotic reactions and synthesis pathways stimulated by insulin. Moreover, in rat mitochondria, mtNOS is phosphorylated in an Akt-sensitive domain at Ser1412. The Akt/protein kinase B [PKB], a serine/threonine protein kinase with high homology for protein kinases A and C, was identified as the cellular homologue of the viral oncoprotein v-Akt (herein referred to as Akt). It is now clear that Akt1 and Akt2 have distinct functions, that both kinases are effectors of the insulin-PI3K pathway and that, Akt2 deficiency associates to a diabetes mellitus-like syndrome [18].
###end p 11
###begin p 12
###xml 651 658 651 658 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 507 510 <span type="species:ncbi:10116">rat</span>
We therefore link here for the first time the mtNOS activity that results from nNOS confinement to muscle mitochondria with the respective rates of oxidative utilization of glucose or of glycogen synthesis induced by insulin. We postulate that insulin signaling activates Akt2, which not only activates the GLUT4 recycling pathway but also increases NOS activity in the organelles in an attempt to restrain mitochondria, thus favoring the replenishment of glycogen and fat energy stores. To that, we used a rat model of hyperinsulinemia with normal glycemia that allowed testing lasting effects of insulin on mitochondria. We succeeded in creating an in vivo comparative metabolic condition in which nNOS- and mtNOS-deficient muscles increase glucose and oxygen utilization and reciprocally restrict glycogen-synthesis providing molecular basis for understanding a NO-dependent progression of metabolic syndrome and type 2 diabetes.
###end p 12
###begin title 13
Results
###end title 13
###begin title 14
Insulin increases p-Akt2 in skeletal muscle mitochondria
###end title 14
###begin p 15
###xml 389 398 389 398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001749-g001">Figure 1A</xref>
###xml 578 586 578 586 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001749-g001">Figure1B</xref>
###xml 943 952 922 931 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001749-g001">Figure 1C</xref>
###xml 1060 1069 1039 1048 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001749-g001">Figure 1D</xref>
###xml 1119 1126 1098 1105 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
Under fairly constant stimulation, insulin early increased the expression of Akt2 and phospho-Akt (p-Akt) in cytosol and mitochondria from skeletal muscle; thereafter, only mitochondrial Akt2 and p-Akt remained very high up to twelve hours after insulin (by about 4 and 6 folds, respectively). In contrast, insulin effects on Akt1 were poor and non-significant in the different fractions (Figure 1A). Flow cytometry of the isolated and purified mitochondria confirmed a net increase of p-Akt fluorescence, with a similar temporal kinetics to that detected by western blotting. (Figure1B). To test p-Akt2 activity under these experimental conditions, we measured the activation of the natural target of Akt, glycogen synthase kinase (GSK-3alpha/beta), to its phosphorylated form (p-GSK-3alpha/beta). Early in the experiment, p-GSK-3alpha/beta peaked up in cytosol and mitochondria and those levels declined for the remainder of the experiment (Figure 1C). Submitochondrial fractionation demonstrated that p-Akt is localized at the inner mitochondrial membrane (Figure 1D). Selective increase of muscle Akt2 suggests the in vivo accumulation of mitochondrial p-Akt2 in the insulin-stimulated skeletal muscle.
###end p 15
###begin title 16
Insulin selectively increases p-Akt2 signal in skeletal muscle mitochondria.
###end title 16
###begin p 17
###xml 222 229 222 229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Methods</xref>
###xml 245 254 245 254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001749.s002">Figure S2</xref>
###xml 497 498 497 498 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 508 510 508 510 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DF</italic>
###xml 517 518 517 518 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 543 544 543 544 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 554 556 554 556 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DF</italic>
###xml 563 564 563 564 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 594 595 594 595 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 605 607 605 607 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DF</italic>
###xml 614 615 614 615 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1413 1414 1402 1403 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 1423 1425 1412 1414 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DF</italic>
###xml 1432 1433 1421 1422 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1457 1458 1446 1447 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 1467 1469 1456 1458 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DF</italic>
###xml 1476 1477 1465 1466 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 73 76 <span type="species:ncbi:10116">rat</span>
###xml 176 181 <span type="species:ncbi:9606">human</span>
(A) Representative western blots of Akt1, Akt2, and p-Akt in proteins of rat skeletal muscle during hyperinsulinemic-normoglycemic status as achieved by s.c. administration of human insulin glargine plus oral sucrose (see Methods and Supporting Figure S2). Respective densitometries from 6-7 samples from separate experiments were obtained after digital image analysis and normalized to the actin band for cytosol fraction and to the complex IV subunit I band for mitochondria (Akt2 mitochondria: F = 39.03, DF = 23, P = 0.000; p-Akt cytosol: F = 111.8, DF = 23, P = 0.000; p-Akt mitochondria: F = 77.48, DF = 25, P = 0.000). Figure shows that after 12 hours increase of Akt2 and p-Akt2 is selectively confined to mitochondria. (B) Differential flow cytometry histograms of 100 microg of purified mitochondria isolated from controls (C) and insulin-treated animals were obtained with 1: 1000 fluorescent antibody anti-p-Akt in a mitochondrial population previously delimited with MitoTracker Red 580. Histograms show a kinetics similar to western blotting. (C) An Akt activity assay was performed three times by immunoprecipitation of mitochondria and cytosol proteins with anti-p-Akt antibody. After further immobilization, the proteins were detected with the anti-p-Ser21/9-GSK-3alpha/beta antibody (1:1000). The assay confirms the insulin-induced kinetics of p-Akt in the fractions as in (A) and (B) (Cytosol: F = 8.46, DF = 15, P = 0.003, Mitochondria: F = 8.15, DF = 15, P = 0.003). (D) Western blot shows submitochondrial localization of p-Akt at the inner mitochondrial membrane, as controlled by duplicate with an antibody specific for subunit IV of cytochrome oxidase. Data are mean+/-SEM.; * p<.05 respect to controls by ANOVA and Dunnett test.
###end p 17
###begin title 18
Insulin boosts nNOS activity in mitochondria
###end title 18
###begin p 19
###xml 237 246 237 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001749-g002">Figure 2A</xref>
###xml 421 430 421 430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001749-g002">Figure 2B</xref>
###xml 537 538 537 538 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 549 550 549 550 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 703 719 703 719 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001749-g002">Figure 2C and 2D</xref>
###xml 874 883 874 883 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001749.s001">Figure S1</xref>
###xml 1108 1117 1108 1117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001749-g002">Figure 2E</xref>
We next examine the relationship between the enhanced insulin-p-Akt2 pathway and the mitochondrial nNOS activity. At maximal mitochondrial p-Akt2, mtNOS activity proportionally increased by about 8 fold and remained high up to 24 hours (Figure 2A). Accordingly, high mitochondrial NO concentration was revealed by flow cytometry of isolated organelles with 4-amino-5-methyl-amino-2', 7'-difluorescein diacetate (DAF-FM) (Figure 2B). To link NO to metabolic signaling, the muscle was challenged with insulin and the phosphatidyl-inositide3-kinase (PI3K) inhibitor LY294002, that resulted in a considerable 75% reduction in mitochondrial NOS activity and in blocking p-Akt accumulation in the organelles (Figure 2C and 2D). Taking into consideration that insulin elicits antagonistic responses, we searched for the optimal dose to obtain maximal NOS activity in mitochondria (Figure S1). Interestingly, remarkable effects on mtNOS were precisely achieved at half-dose insulin while they were less significant at the highest dose. Increase of NOS activity was not associated with changes in protein expression (Figure 2E), and other isoforms were not found in the organelles (not shown).
###end p 19
###begin title 20
Insulin-PI3K signaling triggers high mitochondrial NOS activity.
###end title 20
###begin p 21
###xml 87 88 87 88 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 130 131 130 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 141 143 141 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DF</italic>
###xml 150 151 150 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 175 176 175 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 187 189 187 189 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DF</italic>
###xml 196 197 196 197 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 602 603 598 599 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 610 612 606 608 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DF</italic>
###xml 619 620 615 616 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 738 739 734 735 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 749 751 745 747 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DF</italic>
###xml 758 759 754 755 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 782 783 778 779 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 793 795 789 791 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DF</italic>
###xml 802 803 798 799 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 922 930 918 926 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001749-g001">Figure 1</xref>
###xml 1160 1161 1156 1157 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 1171 1173 1167 1169 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DF</italic>
###xml 1180 1181 1176 1177 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1458 1459 1448 1449 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 1469 1471 1459 1461 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DF</italic>
###xml 1478 1479 1468 1469 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1494 1495 1484 1485 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 1505 1507 1495 1497 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DF</italic>
###xml 1514 1515 1504 1505 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1526 1527 1516 1517 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1532 1534 1522 1524 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs</italic>
###xml 1626 1627 1616 1617 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 1637 1639 1627 1629 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DF</italic>
###xml 1646 1647 1636 1637 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1671 1672 1649 1650 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 411 415 <span type="species:ncbi:262676">Mito</span>
(A) Time-course of mitochondrial NOS activity after insulin administration measured by 3H-L-citrulline formation (n = 8; cytosol: F = 30.62, DF = 31, P = 0.000; mitochondria: F = 290.84, DF = 31, P = 0.000). (B) Matrix NO level appraised by DAF-FM fluorescence by flow-cytometry of isolated mitochondria; fluorescence was selectively analyzed in a mitochondrial population delimited by previous incubation with Mito Tracker Red 580 (C) mtNOS activity of mitochondria isolated from 200 mg of muscle slices preincubated by 30 min with 12 nM of insulin or 100 microM of LY29400 (PI3K-specific inhibitor) (F = 38, DF = 27, P = 0.000). (D) Representative western blot of muscle p-Akt2 distribution under the same conditions as in C. (cytosol: F = 14.75, DF = 15, P = 0.000; mitochondria F = 13.63, DF = 15, P = 0.000). (E) Expression of mtNOS and nNOS mRNA assessed by western blotting and RT-PCR, under the same conditions of Figure 1. (F) Polarographic determination of oxygen uptake of 100 mg of sliced gastrocnemius and extensor digitorum longus muscles obtained after insulin administration in Robinson buffer with 5 mM of glucose as substrate, pH 7.4 (n = 6; F = 18.32, DF = 22, P = 0.000). (G) State 3 oxygen uptake of mitochondria isolated from muscles was measured under the same conditions with malate-glutamate and ADP at 30degreesC in MSHE buffer, pH 7 and in the presence of L-NMMA, L-Arg alone or together with NOS inhibitor L-NMMA (n = 3-12; 12 h: F = 13.83, DF = 15, P = 0.000; 24 h F = 15.69, DF = 37, P = 0.000, *P<.05 vs respective basal values by Dunnett posthoc test; basal control and insulin-treated groups: F = 45.21, DF = 23, P = 0.000, double dagger P<.05 vs control by Dunnett posthoc test). In brackets, the percentage of variation respect to basal or L-arginine, respectively.
###end p 21
###begin p 22
###xml 86 87 86 87 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 138 139 138 139 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 192 193 192 193 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 256 257 256 257 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 294 303 294 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001749-g002">Figure 2F</xref>
###xml 471 472 471 472 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 479 488 479 488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001749-g002">Figure 2G</xref>
###xml 519 520 519 520 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 696 697 696 697 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 791 792 791 792 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 799 808 799 808 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001749-g002">Figure 2G</xref>
###xml 951 952 951 952 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1056 1065 1056 1065 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001749-g002">Figure 2G</xref>
To quantify the inhibitory effects of NO on the electron transfer chain, we measured O2 uptake in muscle slices and mitochondria. Muscle O2 uptake peaked 3 hours after insulin administration (P<.05 respect control), but significantly decreased at 12-24 h (P<.05 either respect control or 3 h) (Figure 2F). In accord, at 12-24 h insulin-administered animals with maximal mtNOS activity had only 40-50% of the mitochondrial respiratory rate of control non-treated animals (P<.05) (Figure 2G). Likewise, in those periods O2 utilization was maximally restricted to 20-40% of the control values by supplementation of organelles with L-arginine. Dependence of NO was as well revealed by the fact that O2 inhibition was significantly relieved by the NOS inhibitor N-monomethyl-L-arginine (L-NMMA) (P<.05) (Figure 2G). To discern the effect of mtNOS in the different periods, we calculated the sum of opposite effects of NOS substrate and inhibitor on basal O2 utilization that determines the mitochondrial NOS functional activity on respiration (11):In accord to Figure 2G, mtNOS functional activity on respiration was maximal at 12 (91%) and 24 h (46%) post insulin treatment while at 3 h, it did not change respect to the control values (19%).
###end p 22
###begin p 23
###xml 96 102 96 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">within</italic>
###xml 166 173 166 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ex vivo</italic>
###xml 233 236 233 236 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">473</sup>
###xml 233 236 233 236 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>473</sup></bold>
###xml 244 247 244 247 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">308</sup>
###xml 244 247 244 247 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>308</sup></bold>
###xml 414 415 414 415 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 485 494 485 494 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001749-g003">Figure 3A</xref>
###xml 508 509 508 509 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 932 941 932 941 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001749-g003">Figure 3B</xref>
To test whether these effects actually depend on p-Akt2 and whether p-Akt2 acts directly on NOS within mitochondria, we next incubated organelles from control muscle ex vivo with recombinant active Akt1 and Akt2 phosphorylated at Ser473 and Thr308. In the presence of ATP and substrate, both phosphorylated Akt1 and Akt2 translocated to energized mitochondria and were detected even when incubated with proteinase K, whereas dephosphorylated Akt1 and Akt2 remained in the supernatant (Figure 3A); proteinase K removed non-translocated proteins that associate to the cytosol face of the outer mitochondrial membrane. In addition, when mitochondria charged with active Akt1 or Akt2 were exposed to DAF-FM, a peak of fluorescence was detected only in those treated with phosphorylated Akt2; this effect was not observed in mitochondria supplemented with dephosphorylated Akt and dissapeared by co-incubation with NOS inhibitor L-NMMA (Figure 3B). These results indicate that, at constant nNOS expression, subcellular distribution of p-Akt2 accounts for the temporal kinetics of nNOS activation in cytosol and mitochondria.
###end p 23
###begin title 24
Phosphorylation allows translocation of Akt1 and Akt2 to mitochondria, but only p-Akt2 increases matrix NO.
###end title 24
###begin p 25
###xml 43 50 43 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ex vivo</italic>
###xml 286 287 280 281 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 431 432 425 426 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 992 1001 980 989 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001749-g001">Figures 1</xref>
###xml 1006 1007 994 995 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001749-g002">2</xref>
###xml 90 93 <span type="species:ncbi:10116">rat</span>
(A) Translocation of Akt1 and 2 was tested ex vivo in purified mitochondria isolated from rat muscle Mitochondria were suspended in MSHE buffer with NADH and ATP (pH7.4), incubated with recombinant His-tagged p-Akt1 and p-Akt2 proteins for 30 min at 30degreesC and centrifuged at 10000 g by 10 min to separate supernatant from mitochondrial pellet further resuspended in phosphate buffer saline (PBS) and incubated with proteinase K and compared with non-phosphorylated Akt. Western blots were performed with anti-His-tag (upper), anti-total Akt (middle) and anti-p-Akt antibodies (bottom). (B) To detect mitochondrial NO, flow cytometry histograms from isolated mitochondria (1 mg protein/ml) were obtained with DAF-FM in the same conditions of (A) and after incubating the organelles for 30 min a 37degreesC with recombinant phosphorylated and non-phosphorylated Akt1 and Akt2 alone or plus 3 mM L-NMMA. The histograms were obtained in a mitochondrial population previously delimited as in Figures 1 and 2.
###end p 25
###begin title 26
Mitochondrial nNOS is phosphorylated by translocated p-Akt2: a cooperative kinetics
###end title 26
###begin p 27
###xml 202 204 198 200 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 416 425 412 421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001749-g004">Figure 4A</xref>
###xml 755 762 751 758 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 890 899 886 895 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001749-g004">Figure 4B</xref>
###xml 1080 1089 1076 1085 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001749-g005">Figure 5A</xref>
###xml 630 634 <span type="species:ncbi:10116">rats</span>
To confirm that the increase in mtNOS activity was a product of nNOS phosphorylation by translocated p-Akt, mitochondria from insulin-administered animals were supplemented with cold ATP and 15 mC gamma32P-ATP and additional recombinant Akt2 before being subjected to autoradiography. In these conditions, a spontaneous signal of phospho-mtNOS was detected in skeletal muscle mitochondria with a high p-Akt2 charge (Figure 4A), that was further increased by exogenous recombinant p-Akt2. To confirm specificity, mitochondria were also isolated from nNOS-deficient muscle directly electroporated with nNOS siRNA. The right legs of rats were injected with nNOS siRNA and the left ones with an empty vector, and both were subjected to direct electroporation in vivo. These mitochondria exhibited low mtNOS content and therefore the Akt2-induced phosphorylation signal substantially decreased (Figure 4B). In accord, direct injection of Akt2 siRNA produced a dose-dependent inhibitory effect on mtNOS activity (60% at the highest dose), similar to the reduction of p-Akt2 and p-GSK3 (Figure 5A).
###end p 27
###begin title 28
Insulin promotes mitochondrial NOS phosphorylation.
###end title 28
###begin p 29
###xml 299 301 295 297 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 390 398 386 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001749-g003">Figure 3</xref>
###xml 627 634 623 630 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
(A) Representative autoradiogram of mtNOS phosphorylation in organelles isolated from the gastrocnemius muscle of animals administered with insulin at p-Akt2 peak concentration (12 h). Mitochondria (2 mg of protein) were incubated in 50 MSHE with 2 mM of cold ATP and 2 mM of NADH and 10 mC of gamma32P-ATP with or without p-Akt2 or dephosphorylated Akt2 (*), as described in the legend of Figure 3. To the right, we show stable nNOS content in the same membrane of autoradiogram by western blot electrophoretic run. (B) Left panel: Autoradiogram of mitochondrial proteins isolated from the gastrocnemius muscle electroporated in vivo with empty pRNAT-U6.1/Neo vector (1) or with 10 microg of siARN nNOS (2) as compared with brain homogenate (3). Isolated proteins were processed as described in A; nNOS deficiency confirms insulin-induced mtNOS phosphorylation. Right panel shows a representative western blot of nNOS protein from the same electrophoresis.
###end p 29
###begin title 30
Translocated p-Akt2 phosphorylates and activates NOS through positive cooperative effects.
###end title 30
###begin p 31
###xml 332 334 332 334 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DF</italic>
###xml 341 342 341 342 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 384 385 384 385 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 395 397 395 397 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DF</italic>
###xml 403 404 403 404 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 576 577 576 577 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 585 587 585 587 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DF</italic>
###xml 594 595 594 595 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 613 614 613 614 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 623 625 623 625 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DF</italic>
###xml 632 633 632 633 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 708 716 708 716 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001749-g002">Figure 2</xref>
###xml 832 833 824 825 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 164 168 <span type="species:ncbi:10116">rats</span>
(A) Dependence of mtNOS phosphorylation on p-Akt2 pathway is demonstrated by measuring the mtNOS activity of mitochondria isolated from the gastrocnemius muscle of rats treated with insulin at crescent siRNA Akt-2 (black bars), as compared with vehicle (grey bars), and muscle from non-inoculated animals (white) (n = 3; F = 66.55, DF = 11, P = 0.000; vehicle vs siRNA Akt-2 at 24 h: t = 18.05, DF = 4, P = 0.000). On the right, the signals of p-Akt and p-GSK-3 measured at 12 hours, which serve as controls, are controlled by western blotting and densitometry (n = 6; pAkt2: t = 8.4, DF = 10, P = 0.000; p-GSK3: t = 8.42, DF = 10, P = 0.001); The threshold for significance is the same as that described in Figure 2). (B) Kinetics of pure recombinant nNOS activity in a lipid phase with 10 microM of cholesterol and 20 microM of BH4; the dashed curve corresponds to non-phosphorylated nNOSalpha and the continuous curve to the cooperative shift of nNOSalpha phosphorylated by recombinant p-Akt2, as shown in intact mitochondria. Each point was done by duplicate/triplicate.
###end p 31
###begin p 32
###xml 174 183 174 183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001749-g005">Figure 5A</xref>
###xml 382 384 378 380 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 417 422 413 418 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 478 482 474 478 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1179</sup>
###xml 478 482 474 478 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>1179</sup></bold>
###xml 508 512 504 508 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001749-Fulton1">[19]</xref>
###xml 744 749 740 745 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 826 834 822 830 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RXRXXS/T</italic>
###xml 842 846 838 842 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1412</sup>
###xml 842 846 838 842 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>1412</sup></bold>
###xml 918 922 914 918 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001749-Elfering1">[20]</xref>
###xml 1042 1043 1038 1039 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 1116 1125 1112 1121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001749-g005">Figure 5B</xref>
###xml 1248 1252 1244 1248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001749-Adak1">[21]</xref>
###xml 1492 1493 1488 1489 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
This effect suggests that the insulin-dependent increase in NOS activity is based upon the kinetic variations induced by Akt2-related enzyme phosphorylation in mitochondria (Figure 5A). To test this hypothesis, His-tagged nNOS was purified from bacteria transfected with cDNA in pCWori+ vector, and enzyme activity was assayed for phosphorylation in the presence of p-Akt2 and gamma32PATP. The pioneer work by Fulton et al reported that Akt activates eNOS by phosphorylating Ser1179 in transfected COS cells [19]. In their study, analogous phosphorylation of nNOS was observed only when the transfected construct had a myristoylation consensus site, indicating that attachment to membranes is also required for enzyme phosphorylation. Elfering et al reported that mtNOS is myristoylated and has only one Akt-sensitive domain (RXRXXS/T) at Ser1412, which has been reported to be phosphorylated in the Maldi/MS analysis [20]. We therefore measured K' for L-arginine in phosphorylated or non-phosphorylated recombinant nNOS in the presence of BH4 and cholesterol, as a lipid phase representative of membrane insertion (Figure 5B). The S1412G nNOS mutation, which simulates phosphorylation, increases the heme reduction rate and decreases NO yield and [21] electron transfer in the calmodulin-bound state. Here, a sigmoid kinetic curve was noted for both the phosphorylated and non-phosphorylated nNOS, but with different Hill slopes (3.7 and 1.9), findings that suggest a cooperative behavior (r2 = 0.99 and 0.97); in the lipid phase, p-Akt2 reduced K' for L-Arg from 19 to 11 microM.
###end p 32
###begin title 33
mtNOS is the final insulin/Akt effector that regulates muscle utilization of available glucose
###end title 33
###begin p 34
###xml 520 529 520 529 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001749-g006">Figure 6A</xref>
###xml 618 627 618 627 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001749-g002">Figure 2B</xref>
###xml 931 932 931 932 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 938 939 938 939 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1087 1088 1087 1088 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 1089 1090 1089 1090 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1096 1098 1096 1098 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">14</sup>
###xml 1100 1102 1100 1102 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2 </sub>
###xml 1201 1210 1201 1210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001749-g006">Figure 6B</xref>
###xml 1601 1610 1594 1603 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001749-g006">Figure 6C</xref>
###xml 1856 1865 1849 1858 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001749-g006">Figure 6C</xref>
###xml 309 312 <span type="species:ncbi:10116">rat</span>
A cornerstone of this study is that, after energy replenishment, mitochondrial oxidations ought to be depressed to allow substrates to be deposited as macromolecules. We tested the contribution of mtNOS to the balance maintained between mitochondrial and intermediary metabolism, by injecting siRNA nNOS into rat gastrocnemius muscles with high nNOS content. This procedure reduced nNOS mRNA levels as well as protein expression and activity in mitochondria by approximately 50-77% in comparison to constant complex IV (Figure 6A). Under these experimental conditions and because of the decreased levels of matrix NO (Figure 2B), oxygen uptake became insensitive to insulin administration and remained high in the nNOS-silenced muscles. The increase of glucose uptake elicited by insulin administration was not modified by siRNA nNOS. Instead, siRNA nNOS markedly increased glucose utilization evidenced by complete oxidation to CO2 and H2O. Thus, at fixed insulin with similar glucose uptake and glycogen synthase activity, high oxygen utilization with siRNA nNOS was in line with high 3H2O and 14CO2 production rates, i.e., 50-100% higher in the right siRNA-treated muscle than in the left control (Figure 6B). No significant variations of metabolic rate were detected at low mtNOS activity. Interestingly, under these conditions the glucose used for glycogen synthesis was halved in the siRNA nNOS-treated muscle; at normal mtNOS content similar effects were observed when the Akt2 gene was silenced, reducing protein expression and phosphorylation of GSK-3alpha/beta by 56% and 75%, respectively (Figure 6C). In accordance with previous reports, direct administration of siRNA Akt2 did not result in significant variations of glucose uptake or glycogen synthase activity, although the peak of glucose uptake decreased at 24 h in the deficient muscles (Figure 6C).
###end p 34
###begin title 35
mtNOS Is a final insulin/Akt effector regulating muscle utilization of available glucose.
###end title 35
###begin p 36
###xml 358 359 354 355 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 368 370 364 366 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DF</italic>
###xml 377 378 373 374 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 406 407 402 403 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 416 418 412 414 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DF</italic>
###xml 425 426 421 422 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 454 455 450 451 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 464 466 460 462 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DF</italic>
###xml 473 474 469 470 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 686 687 682 683 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 693 694 689 690 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 935 936 931 932 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 945 946 941 942 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 956 958 952 954 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DF</italic>
###xml 965 966 961 962 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 976 978 972 974 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">14</sup>
###xml 980 981 976 977 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 983 984 979 980 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 993 995 989 991 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DF</italic>
###xml 1002 1003 998 999 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1015 1017 1011 1013 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">14</sup>
###xml 1041 1042 1037 1038 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 1051 1053 1047 1049 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DF</italic>
###xml 1060 1061 1056 1057 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1094 1095 1090 1091 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 1105 1107 1101 1103 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DF</italic>
###xml 1114 1115 1110 1111 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1144 1145 1140 1141 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 1154 1156 1150 1152 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DF</italic>
###xml 1163 1164 1159 1160 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1191 1192 1187 1188 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1201 1202 1197 1198 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 1212 1214 1208 1210 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DF</italic>
###xml 1221 1222 1217 1218 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1232 1233 1228 1229 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 1234 1235 1230 1231 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1238 1239 1234 1235 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 1249 1251 1245 1247 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DF</italic>
###xml 1258 1259 1254 1255 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1269 1271 1265 1267 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">14</sup>
###xml 1273 1274 1269 1270 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1276 1277 1272 1273 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 1286 1288 1282 1284 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DF</italic>
###xml 1295 1296 1291 1292 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1309 1311 1305 1307 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">14</sup>
###xml 1335 1336 1331 1332 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 1345 1347 1341 1343 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DF</italic>
###xml 1354 1355 1350 1351 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1388 1389 1384 1385 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 1399 1401 1395 1397 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DF</italic>
###xml 1408 1409 1404 1405 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1438 1439 1434 1435 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 1448 1450 1444 1446 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DF</italic>
###xml 1457 1458 1453 1454 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1620 1621 1616 1617 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 1630 1632 1626 1628 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DF</italic>
###xml 1638 1639 1634 1635 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1680 1682 1676 1678 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">14</sup>
###xml 1684 1685 1680 1681 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1687 1688 1683 1684 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 1698 1700 1694 1696 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DF</italic>
###xml 1706 1707 1702 1703 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1720 1722 1716 1718 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">14</sup>
###xml 1746 1747 1742 1743 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 1756 1758 1752 1754 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DF</italic>
###xml 1763 1764 1759 1760 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1838 1846 1834 1842 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001749-g004">Figure 4</xref>
###xml 1848 1849 1844 1845 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1854 1856 1850 1852 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs</italic>
###xml 1935 1936 1931 1932 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
(A) Representative western blot of disrupted and normal mtNOS, densitometries, and mtNOS activities of mitochondria isolated from right and left gastrocnemius of the same animal, 36 h after direct electroporation of respectively 10 microg of siRNA nNOS or empty pRNAT-U6.1/Neo vector to muscle, as described in Experimental Procedures. (n = 6; densitometry: t = 6.55, DF = 10, P = 0.000; activity at 12 h: t = 6.07, DF = 10, P = 0.000; activity at 24 h: t = 2.22, DF = 10, P = 0.05) (B) To test the interdependence of oxidative and intermediary metabolism as related to activation of mtNOS, metabolic studies including oxygen uptake, glycogen synthesis, complete glucose oxidation to CO2 and H2O, glucose uptake and glycogen synthase activity were performed in nNOS-silenced right gastrocnemius- and vector-administered left muscles of the same animal in parallel under the different conditions by radioactive methods (n = 6; vector: O2 uptake, F = 10.47, DF = 23, P = 0.000; 14CO2, F = 5.06, DF = 23, P = 0.02; (U-14C)-glucose to glycogen, F = 8.61, DF = 23, P = 0.006; 2-deoxyglucose uptake, F = 22.55, DF = 23, P = 0.000; glycogen synthase, F = 3.59, DF = 23, P = 0.032; with siRNAnNOS: O2 uptake, F = 13.78, DF = 23, P = 0.000; 3H2O, F = 17.34, DF = 23, P = 0.000; 14CO2, F = 4.25, DF = 23, P = 0.034; (U-14C)-glucose to glycogen, F = 8.08, DF = 23, P = 0.004; 2-deoxyglucose uptake, F = 12.90, DF = 23, P = 0.000; glycogen synthase, F = 3.62, DF = 23, P = 0.031). (C) Metabolic studies were performed by previous administration of crescent siRNAAkt2 or vehicle under conditions analogous to A and B (n = 3, p-GSK3: t = 7.47, DF = 4, P = 0.002; at 24 h, vehicle vs siRNAAkt2, 14CO2: t = -3.23, DF = 4, P = 0.032; (U-14C)-glucose to glycogen: t = 2.85, DF = 4 P = 0.05). The threshold for significance is the same as that described in Figure 4.*P<.05 vs controls or between nNOS or Akt2 silenced and not-silenced muscle samples; ** P<.05 between different times of insulin administration.
###end p 36
###begin title 37
Discussion
###end title 37
###begin p 38
###xml 146 149 146 149 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">via</italic>
We herein demonstrate the modulatory connection between insulin signaling and mitochondrial function: insulin decreases the muscle oxidative rate via mitochondrial NO. We confirmed this finding using a number of different experimental approaches, showing that the effect relies on p-Akt2-selective phosphorylation of mitochondrial nNOS, after kinase translocation to the organelles.
###end p 38
###begin p 39
###xml 182 186 175 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001749-Bijur1">[22]</xref>
###xml 388 395 381 388 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ex vivo</italic>
###xml 397 406 390 399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001749-g003">Figure 3A</xref>
###xml 409 416 402 409 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vivo</italic>
###xml 586 590 579 583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001749-Sasaoka1">[23]</xref>
###xml 717 726 710 719 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001749-g003">Figure 3B</xref>
###xml 796 799 789 792 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">via</italic>
###xml 975 979 968 972 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1412</sup>
###xml 975 979 968 972 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>1412</sup></bold>
###xml 1088 1092 1081 1085 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001749-Rameau1">[24]</xref>
A rapid translocation of p-Akt to the mitochondria and the phosphorylation of target GSK-3alpha/beta by insulin-PI3K were previously reported by Bijur and Jope in a variety of cells [22]. It is confirmed here that phosphorylation is absolutely required for Akt translocation to muscle mitochondria and that, in this framework, both p-Akt1 and p-Akt2 can be translocated to the organelles ex vivo (Figure 3A). In vivo however, insulin only increases p-Akt2 probably because of high expression of SH2-phophatase that selectively dephosphorylates p-Akt1, but not p-Akt2 in skeletal muscle [23]. Moreover, solely translocated p-Akt2 and not p-Akt1 induced a robust generation of NO by mtNOS in the isolated mitochondria (Figure 3B). Considering that eNOS is activated in the caveolae by insulin/PI3K via p-Akt1, specific functional and topographic connections between NOS and Akt isoforms become evident. In this way, a recent study reported p-Akt2 phosphorylation of nNOS at Ser1412 in synaptosomes, suggesting the functioning of this mechanism in different organs and subcellular fractions [24].
###end p 39
###begin p 40
###xml 137 141 137 141 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1412</sup>
###xml 137 141 137 141 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>1412</sup></bold>
###xml 143 153 143 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001749-g004">Figures 4B</xref>
###xml 158 160 158 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001749-g007">7A</xref>
###xml 415 417 415 417 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 562 566 562 566 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1400</sup>
###xml 562 566 562 566 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>1400</sup></bold>
###xml 566 570 566 570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001749-Tiso1">[25]</xref>
###xml 636 645 636 645 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001749-g004">Figures 4</xref>
###xml 650 651 650 651 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001749-g005">5</xref>
###xml 707 711 707 711 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1412</sup>
###xml 707 711 707 711 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>1412</sup></bold>
###xml 719 723 719 723 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1410</sup>
###xml 719 723 719 723 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>1410</sup></bold>
###xml 852 861 852 861 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001749-g007">Figure 7A</xref>
The phosphorylation of nNOS/mtNOS by p-Akt2 involves cooperative effects centered at the C-terminal tail that contains the Akt motif (Ser1412; Figures 4B and 7A). Although structural changes of phosphorylated nNOS are not defined yet, it is worth noticed that C-terminal tail participates in the regulation of nNOS activity. Allosteric inhibition of electron transfer from NADPH to FAD and poor NO release at low Ca2+-calmodulin level result from electrostatic interactions between acidic negative charges of 2'phosphate of NADP and positive charges of basic Arg1400[25]. On this basis, we surmise that p-Akt2 activation of nNOS/mtNOS (Figures 4 and 5) promote opposed electrostatic interactions between Ser1412 and Arg1410 that, in the lipid phase, equilibrates the oscillation of the C-terminal tail to cooperatively increase the NO production rate (Figure 7A).
###end p 40
###begin title 41
Scheme of nNOS activation and the modulation of muscle metabolism.
###end title 41
###begin p 42
###xml 387 390 <span type="species:ncbi:10116">rat</span>
(A) A pendulous movement of the nNOS C-terminal tail (in blue) by opposed electrostatic interactions is suggested to explain cooperative positive modulation of nNOS phosphorylated by p-Akt2; nNOS (gi: 16258810) was represented with Pymol (DeLano Scientific, Palo Alto, CA, USA). (B) Scheme of the modulation of mitochondrial respiration and glucose metabolism by the Akt2/nNOS couple in rat skeletal muscle.
###end p 42
###begin p 43
###xml 154 155 154 155 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 272 273 272 273 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 281 284 281 284 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">via</italic>
###xml 433 434 433 434 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 517 518 517 518 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 524 525 524 525 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 604 606 604 606 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Km</italic>
###xml 658 659 658 659 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 752 754 752 754 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;7</sup>
###xml 757 759 757 759 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;8</sup>
###xml 818 820 818 820 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;5</sup>
###xml 1117 1126 1117 1126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001749-g007">Figure 7B</xref>
Different approaches confirmed in this study that phosphorylation of muscle mtNOS increases mitochondrial NO yield by several folds and reduces systemic O2 utilization. We show here as well that the temporal activation of mtNOS and the resulting decline of mitochondrial O2 uptake via NO drive the muscle insulin-transition from glucose oxidation to glycogen deposition. In absence of NO or, in nNOS-silenced muscles, mitochondrial O2 uptake is completely released leading to a preferential oxidation of glucose to CO2 and H2O; in these conditions, prevalent oxidation of glucose reflects the respective Km of regulatory enzymes like cytochrome oxidase for O2 and pyruvate dehydrogenase complex for acetyl-CoA, at least one order of magnitude lower (10-7-10-8 M, ref 26), than that of glycogen synthase for glucose (10-5 M, ref 27). In contrast, in the presence of NO, glucose utilization is delivered to glycogen synthesis. These results therefore support the notion that a discrete inhibition of the respiratory chain as produced by NO is required to reduce oxidative rates and to allow glycogen or fat deposition (Figure 7B).
###end p 43
###begin p 44
###xml 81 90 81 90 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001749.s001">Figure S1</xref>
###xml 173 178 173 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i.e.,</italic>
###xml 392 396 392 396 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001749-Kim1">[28]</xref>
###xml 636 645 636 645 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001749-g002">Figure 2G</xref>
###xml 839 848 839 848 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001749-g002">Figures 2</xref>
###xml 853 854 853 854 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001749-g006">6</xref>
###xml 997 1001 997 1001 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001749-Stump1">[29]</xref>
At ten-fold higher insulin dose, maximal mtNOS activation was reduced by a half (Figure S1). This fact reminds that insulin activates other mitochondrial reactions as well; i.e., early activation of pyruvate dehydrogenase complex through insulin-inhibition of pyruvate dehydrogenase kinase (PDK4) could transiently compete with NADH/NADPH availability for NOS in skeletal muscle mitochondria [28]. In this study, effects at low and high insulin concentrations thus explain: a) lack of stimulation and null mtNOS activity in muscle at initial blood insulin peak (3 hours); b) high respiratory rate at peak insulin level with null mtNOS (Figure 2G); c) decreased respiratory rate at stable insulin concentration with full mtNOS and, d) physiological alternation of insulin effects promoting complete glucose oxidation or glycogen synthesis (Figures 2 and 6). The increase or decrease of oxygen consumption was previously reported to occur in muscle at respectively high or low insulin concentration [29].
###end p 44
###begin p 45
###xml 501 502 501 502 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 502 506 502 506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001749-Noland1">[30]</xref>
###xml 535 537 535 537 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob</italic>
###xml 537 538 537 538 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 539 541 539 541 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob</italic>
###xml 541 542 541 542 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 654 658 654 658 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001749-GarcaRuiz1">[31]</xref>
###xml 713 714 713 714 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 711 714 711 714 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob<sup>&#8722;</sup></italic>
###xml 717 718 717 718 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 715 718 715 718 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob<sup>&#8722;</sup></italic>
###xml 945 949 945 949 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001749-Barreyro1">[32]</xref>
###xml 1137 1141 1137 1141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001749-Lowell1">[33]</xref>
###xml 1241 1244 1241 1244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001749-Auwerx1">[3]</xref>
###xml 1290 1294 1290 1294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001749-Szendroedi1">[34]</xref>
###xml 141 149 <span type="species:ncbi:405018">cardinal</span>
###xml 250 254 <span type="species:ncbi:10116">rats</span>
###xml 418 422 <span type="species:ncbi:10116">rats</span>
###xml 549 553 <span type="species:ncbi:10090">mice</span>
###xml 719 723 <span type="species:ncbi:10090">mice</span>
###xml 1064 1070 <span type="species:ncbi:9606">humans</span>
The presented data confirm insulin as a normal regulator of oxidative phosphorylation rate in skeletal muscle but as well they could explain cardinal features of the progression of metabolic syndrome and obesity to type 2 diabetes. Zucker Fatty (ZF) rats with a leptin receptor defect exhibit obesity, insulin resistance with hyperinsulinemia and normal glycemia that progress to type 2 diabetes in 6-12 weeks (4); ZF rats have severe mitochondrial inhibition with low oxidation of palmitic acid to CO2[30]. Moreover, leptin-deficient ob-/ob- obese mice exhibit insulin resistance and obesity associated to hyperinsulinemia with mitochondrial inhibition [31]. Preliminary results of our group demonstrated that ob-/ob- mice with metabolic syndrome have increased expression of mtNOS and high mitochondrial NO yield and that mitochondrial inhibition is released by NOS inhibitors or by leptin infusion, both decreasing NO yield in the organelles [32]. As in genetic experimental models of metabolic syndrome, the term mitochondrial dysfunction has been referred in humans as to a condition with decreased oxidation rate and ATP synthesis [33] and, in this context, reduced respiration was reported to contribute to glycogen or fat deposition [3] and can be independent of insulin resistance [34]. Considering the metabolic syndrome as accompanied by insulin resistance with prolonged hyperinsulinemia, such a mitochondrial dysfunction appears to be analogue to the persistent inhibitory effects on mitochondrial respiration demonstrated by the presented data at intermediate insulin concentration.
###end p 45
###begin p 46
###xml 319 323 319 323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001749-Poderoso2">[35]</xref>
###xml 352 356 352 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001749-Riob1">[36]</xref>
###xml 503 507 503 507 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001749-RaskMadsen1">[37]</xref>
###xml 648 650 648 650 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob</italic>
###xml 650 651 650 651 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 652 654 652 654 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob</italic>
###xml 654 655 654 655 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 675 679 675 679 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001749-GarcaRuiz1">[31]</xref>
###xml 722 726 722 726 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001749-Turko1">[38]</xref>
###xml 849 853 849 853 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001749-Yasukawa1">[39]</xref>
###xml 1032 1036 1032 1036 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001749-Brookes1">[17]</xref>
###xml 1286 1290 1286 1290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001749-Mohr1">[40]</xref>
###xml 1601 1605 1597 1601 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001749-Nisoli1">[41]</xref>
###xml 231 234 <span type="species:ncbi:10116">rat</span>
Our findings therefore suggest that the mechanisms for progression to severe mitochondrial dysfunction in type 2 diabetes are contributed by NO-dependent mechanisms. We reported that NO markedly increases superoxide anion yield in rat skeletal muscle mitochondria by inhibiting electron transfer at Complexes I and III [35], finally damaging Complex I [36]. Increased mitochondrial superoxide anion was related to hyperglycemia and insulin resistance, as well as to persistent mitochondrial dysfunction [37]. In the presence of superoxide anion plus nitric oxide, 3-nitrotyrosine was found as a marker of nitration of mitochondrial proteins in the ob-/ob- metabolic syndrome [31] and in experimental and clinical diabetes [38]. Excessive NO leads both to nitrosylation and inactivation of the insulin receptor and Akt, increasing insulin resistance [39]. A number of different NO-based mitochondrial mechanisms can contribute to insulin resistance as well. First, an increase of ADP/ATP ratio due to inhibition of electron transfer [17] can restrict the phosphorylation of insulin receptor substances (IRSs) and the translocation of GLUT4 to the cell membrane. Second, accumulation of NADH due to NO-dependent complex I inhibition can negatively modulate glycolisis and the Krebs cycle [40]. Finally, nitric oxide stimulates mitochondrial biogenesis by increasing PGC 1alpha coactivator and thus could compensate mitochondrial dysfunction in the early metabolic syndrome, while reduced biogenesis with further decay of mitochondrial population has been reported in already established type 2 diabetes [41].
###end p 46
###begin p 47
###xml 461 467 461 467 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">per se</italic>
###xml 827 831 827 831 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001749-Cho1">[18]</xref>
###xml 194 198 <span type="species:ncbi:10090">mice</span>
###xml 630 634 <span type="species:ncbi:10090">mice</span>
From these perspectives, an additional explanation is required for progression of diabetes and tissue damage in hypoinsulinemic status, like type I diabetes, Akt2 deficiency or nNOS knocked out mice. In contrast to activation of insulin-NOS pathway in mitochondria, in these models progressive tissue and mitochondrial damage should not depend on an increased ADP/ATP ratio; it is worth noticed that Akt2 has extramitochondrial effects on GLUT4 and facilitates per se the mechanism of glucose uptake. However, it is apparent as well that weight loss in low-insulin diabetes or severe lypoatrophy in hypoinsulinemic Akt2-deficient mice could occur because of the lack of NOS activation, leading to uncontrolled mitochondrial respiration and to high oxidative stress in the organelles with a marked reduction of glycogen content [18].
###end p 47
###begin p 48
###xml 140 141 140 141 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
We conclude that increase of NO in the mitochondrial compartment by insulin is a powerful physiological resource to properly adjust muscle O2 utilization, while persistence of this mechanism in hyperinsulinemic states is harmful and could contribute to diabetic mitochondrial dysfunction.
###end p 48
###begin title 49
Materials and Methods
###end title 49
###begin title 50
Animals and treatments
###end title 50
###begin p 51
Animals were housed in a temperature-controlled room, provided food, and subjected to a 12:12 dark/light cycle. National Institutes of Health criteria for animal research were followed after approval by the University Hospital.
###end p 51
###begin p 52
###xml 192 201 192 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001749.s002">Figure S2</xref>
###xml 346 349 346 349 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A21</sup>
###xml 346 349 346 349 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>A21</sup></bold>
###xml 355 358 355 358 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B31</sup>
###xml 355 358 355 358 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>B31</sup></bold>
###xml 363 366 363 366 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B32</sup>
###xml 363 366 363 366 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>B32</sup></bold>
###xml 770 779 770 779 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001749.s002">Figure S2</xref>
###xml 936 946 936 946 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ad libitum</italic>
###xml 970 979 970 979 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001749.s002">Figure S2</xref>
###xml 1480 1484 1480 1484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001749-Reinhart1">[43]</xref>
###xml 1872 1876 1860 1864 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001749-Golzio1">[46]</xref>
###xml 69 80 <span type="species:ncbi:10116">Wistar rats</span>
###xml 148 153 <span type="species:ncbi:9606">human</span>
###xml 328 333 <span type="species:ncbi:9606">human</span>
###xml 1196 1201 <span type="species:ncbi:9606">human</span>
###xml 1337 1342 <span type="species:ncbi:9606">human</span>
###xml 1522 1525 <span type="species:ncbi:10116">rat</span>
###xml 1649 1652 <span type="species:ncbi:10116">rat</span>
To achieve a non-invasive hyperinsulinemic-normoglycemic clamp, male Wistar rats [250-300g body wt] were subcutaneously inoculated with long-acting human analogue insulin glargine (Supporting Figure S2, 42-44) or NaCl 0.9% and skeletal muscle was excised at 3, 12 and 24 hours. Insulin glargine, with its three modifications to human insulin (GlyA21, ,ArgB31, ArgB32) is a stable molecule that is soluble in slightly acidic conditions and precipitates in the neutral pH of subcutaneous tissue. Because of these properties, absorption of insulin glargine is delayed and the analogue provides a fairly constant, basal insulin supply without peaks in plasma insulin levels for approximately 24 hours, similar to that achieved by a continuous subcutaneous insulin infusion (Figure S2). During the 24-hour period, active metabolites sustain insulin effects after the decay of the hormone. Animals were allowed to drink water with 5% sucrose ad libitum to avoid hypoglycemia (Figure S2). Without glucose intake, insulin glargine results in hypoglycemia 2-4 h after administration (-15 to 30% of basal values; 45). Plasma insulin levels were followed independently of endogenous hormone with a specific human immunoassay (IMX Microparticle Enzyme Immunoassay, Abbott Labs, Ramsey, MN). Because the cross reactivity between insulin glargine and human insulin is approximately 60%, thus resulting in underestimation of its level in the immune assay, obtained values were multiplied by 1.8 [43]. All experiments were carried out in rat extensor digitorum longus and gastrocnemius red-mixed muscles with appropriate mass (approximately0.6 g per muscle); adult rat muscle is comprised of approximately 4-50% slow oxidative fibers [I] and 20-40% fast oxidative fibers [IIa] with a large mitochondrial population, high glycogen content, and concomitantly, a high level of nNOS activity [46].
###end p 52
###begin title 53
Akt/insulin Signaling Pathway and Nitric Oxide in Muscle Mitochondria
###end title 53
###begin p 54
Muscle mitochondria were isolated from homogenized muscles by differential centrifugation and further purified with Percoll gradients. After purification, the mitochondrial fraction has no more than 10% activity of cytosol lactic dehydrogenase activity or 5% of calreticulin from SRE (western blot) while cytosolic fraction did not express complex I proteins or 39 kDa subunit I of cytochrome oxidase (western blot). Cytosol and mitochondrial expression of nNOS, p-Akt, Akt1, Akt2 and p-GSK-3 alpha/beta was assessed by immunoblotting with specific antibodies and by detecting variations of NO and p-Akt, by flow-cytometry in freshly isolated mitochondria.
###end p 54
###begin p 55
###xml 378 379 372 373 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 385 386 379 380 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
To analyze effects of PI3K pathway on mtNOS, muscles were dissected out and rapidly cut into 20 to 30 mg strips and incubated in a shaking water bath at 30degreesC for 30 min into a 25 ml flask containing 3 ml of oxygenated Robinson buffer supplemented with glucose and 0.1% BSA; strips were homogenized and mitochondria were obtained. Flasks were gassed continuously with 95% O2-5% CO2 throughout the experiment.
###end p 55
###begin p 56
###xml 81 82 81 82 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 100 101 100 101 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 687 688 673 674 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 827 828 805 806 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 890 891 868 869 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1028 1032 990 994 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001749-Franco1">[11]</xref>
###xml 1036 1038 998 1000 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 1160 1161 1122 1123 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</sup>
###xml 1159 1161 1121 1123 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N<sup>G</sup></italic>
###xml 1213 1214 1175 1176 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 1764 1765 1720 1721 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1771 1772 1727 1728 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1302 1305 <span type="species:ncbi:10116">rat</span>
NOS activity was followed in cytosol and purified mitochondria by conversion of [3H]-L-arginine to [3H]-L-citrulline. To detect variations of NO and p-Akt by flow-cytometry, freshly isolated mitochondria were previously incubated for 30 min at 37degreesC with fluorescent anti-p-Akt or 10 microM of DAF-FM and 0.5 microM of MitoTracker Red 580 in PBS 1X. Fluorescence intensity was measured using an Ortho Cytoron Absolute Flow Cytometer [Johnson and Johnson, Raritan, NY]. Submitochondrial p-Akt localization was studied by western blot after hypotonic disruption and differential centrifugation; p-Akt activity was determined with a commercial kit from Cell Signaling (Beverly, MA.). [3H]-L-citrulline assay was done in 50 mM of potassium phosphate buffer, pH 7.5, in the presence of 100 microM of L-arginine, 0.1 microM of [3H]-L-arginine (NEN, Boston, MA.), 0.1 mM of NADPH, 0.3 mM CaCl2, 0.1 microM of calmodulin, 10 microM of tetrahydrobiopterin, 1 microM of FAD, 1 microM of FMN, 50 mM of L-valine and 1 mg/ml of protein [11]. Ca2+-dependent specific activity was calculated by subtracting the remaining activity in the presence of the NOS inhibitor L-NG-methyl-L-arginine (5 mM of L-NMMA) or 2 mM of EGTA 3H arginine assay. NOS activity was measured as the number of mitochondria isolated from rat muscle injected with insulin and from muscle incubated with insulin or LY29400 (PI3K-specific inhibitor). Muscles were dissected out and rapidly cut into 20- to 30-mg strips and incubated in a shaking water bath at 30degreesC for 30 min before being transferred into a 25-ml flask containing 3 ml of oxygenated Krebs-Ringer bicarbonate buffer (KRB) supplemented with 8 mM of glucose, 32 mM of mannitol and 0.1% BSA. Flasks were gassed continuously with 95% O2-5% CO2 throughout the experiment. To measure the mtNOS activity, muscle mitochondria were isolated and purified after incubation, as described previously.
###end p 56
###begin p 57
Total muscle RNA was extracted with Trizol, and RT-PCR was performed under standard conditions.
###end p 57
###begin title 58
Translocation of Akts to mitochondria
###end title 58
###begin p 59
###xml 82 89 82 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ex vivo</italic>
###xml 430 431 426 427 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 577 581 573 577 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001749-Truscott1">[47]</xref>
###xml 709 710 705 706 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Isolated organelles at 1 mg/ml were purified with percoll gradients and incubated ex vivo with pure recombinant active Akt1-GST or Akt2-GST (100 units/ml) (Cell Signaling) dually phosphorylated at Thr-308 and Ser-473 or with isoforms dephosphorylated with acid phosphatase and co-incubated with the NOS inhibitor L-NMMA. Mitochondria were then centrifuged and separated from supernatant, co-incubated with 50 microg/ml proteinase K and DAF-FM, and subjected to flow cytometry to assess fluorescence intensity. To allow translocation of Akt2 to the inner mitochondrial membrane [47], mitochondrial membrane potential was sustained by co-incubating the isolated organelles with 2 mM NADH and 2 mM ATP without Mg2Cl.
###end p 59
###begin title 60
nNOS phosphorylation by p-Akt2
###end title 60
###begin p 61
###xml 74 76 70 72 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 184 187 180 183 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">473</sup>
###xml 184 187 180 183 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>473</sup></bold>
###xml 195 198 191 194 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">308</sup>
###xml 195 198 191 194 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>308</sup></bold>
###xml 272 279 268 275 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 425 428 421 424 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">max</italic>
###xml 436 437 432 433 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">h</sup>
###xml 448 449 444 445 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">h</sup>
###xml 140 145 <span type="species:ncbi:9606">human</span>
###xml 272 279 <span type="species:ncbi:110766|species:ncbi:562">E. coli</span>
NOS phosphorylation was evaluated in a mitochondrial free assay with gamma32P-ATP and cold ATP in MOPS buffer alone or together with active human recombinant Akt2 phosphorylated at Ser473 and Thr308. Recombinant His-tagged nNOS protein was obtained by magnetic field from E. coli transformed in a pcWori+ vector containing the respective cDNA. Kinetics parameters were assessed with GraphPad Software (San Diego, CA); K' = [Vmaxx[L-Arg]h/V]-[L-Arg]h, where h is the calculated Hill coefficient.
###end p 61
###begin title 62
Oxygen uptake
###end title 62
###begin p 63
###xml 45 46 41 42 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Oxygen uptake was measured at 220 microM of O2 in a standard polarograph (IQUIFYB-MADEIC, Buenos Aires, Argentina) in sliced muscle with Robinson buffer or in isolated mitochondria with MSHE buffer with 6 mM of malate plus 6 mM of glutamate, with or without 0.2 mM of ADP, 0.3 mM of L-arginine or 3 mM of L-NMMA.
###end p 63
###begin title 64
In vivo muscle siRNA electroporation
###end title 64
###begin p 65
###xml 1183 1187 1175 1179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001749-Golzio1">[46]</xref>
###xml 1296 1305 1288 1297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001749.s003">Figure S3</xref>
###xml 1252 1255 <span type="species:ncbi:10116">rat</span>
Animals were briefly anesthetized with sodium thiopental [40 mg/kg weight, intraperitoneal], and gastrocnemius muscles were percutaneously treated with one proximal and one distal injection of siRNA nNOS (10 microg/per muscle] [GenScript, NewJersey, N.Y.) (right leg) or empty pRNAT-U6.1/Neo vector (left leg) or with Akt2 siRNA from Santa Cruz Biotechnology (Santa Cruz, CA) (right leg) or vehicle (left leg), in parallel. Each injection was performed in 5 microl free-RNAase solution, slowly in 15-20 s with a Hamilton syringe with a 22 G needle. Around 30 s after injection, electric pulsation was applied. For pulse delivery to muscle, two stainless steel connectors were applied on the needles implanted in muscle. Therefore, the needles were used as electrodes and connected to the generator; in these conditions the depth of insertion was about 0.5 cm and the gap between the two needles was 0.9 cm. The muscle were then electropulsed with selected parameters using the Gene Pulser II Electropulsator (Bio-Rad Laboratories,USA).Voltage (120V), pulse duration (20 ms) and frequency of pulses (1Hz) were all preset on the electropulsator. A train of eight pulses was delivered. [46]. The sequences of nNOS siRNAs were designed on the structure of rat nNOS g.i.: 16258811 and are provided in Figure S3.
###end p 65
###begin title 66
Metabolic studies
###end title 66
###begin p 67
###xml 457 458 456 457 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 461 463 460 462 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2 </sub>
###xml 576 577 569 570 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 583 584 576 577 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 650 651 642 643 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 695 697 686 688 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">14</sup>
###xml 745 746 735 736 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
Thirty six hours after electroporation, insulin was administered at appropriate times and finally, animals were anesthetized and gastrocnemius muscles were removed, weighed, and washed with NaCl (0.9%). Finally, muscles were excised and minced in 0.1-mm layers with a Thomas slicer and 180-200 mg of tissue were placed into three different test tubes containing Krebs-Ringer bicarbonate buffer with 2% BSA pH 7.2 (250 mul/100 mg of tissue) and gassed with O2:CO2 [95:5 vol/vol] for five minutes at 37degreesC. To measure glycogen synthesis and complete glucose oxidation to CO2 and H2O, muscle was supplemented with 0.5 muCi/ml deoxy-D-glucose,2 [1,23H[N]]-[25.0 Ci/mmol], 4 muCi/ml glucose, D-[14C[U]]-[250 mCi/mmol] and 4 muCi/ml glucose D-[5-3H[N] ]-[10.2 Ci/mmol]. Radioactives were from Perkin-Elmer Life and Analytical Sciences, Boston, MA, USA.
###end p 67
###begin p 68
Determinations were done after 12 hours of fasting; to maintain both appropriate light-dark cycle and fasting, samples for glycogen synthesis after 12 hours of insulin administration were obtained at 6:00 PM and for glucose oxidation at 3:00 and 11:00 AM.
###end p 68
###begin p 69
###xml 130 134 130 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001749-Cuendet1">[48]</xref>
###xml 228 232 228 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001749-Leloir1">[49]</xref>
To measure glucose uptake, muscle was placed separately in the appropriate buffers and supplemented with radioactive deoxyglucose [48]. Glycogen synthase activity was measured using the method developed by Leloir and Goldemberg [49].
###end p 69
###begin title 70
Statistical analysis
###end title 70
###begin p 71
###xml 46 54 46 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">post hoc</italic>
###xml 88 89 88 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 140 141 140 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Data were compared with ANOVA and the Dunnett post hoc test or the two-tailed Student's t test as appropriate; significance was accepted at P<.05.
###end p 71
###begin title 72
Supporting Information
###end title 72
###begin p 73
###xml 194 195 194 195 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Muscle mtNOS activity at different doses of insulin glargine. Each value represents separate experiments from animals with insulin (closed circles) and without insulin (closed squares) (n = 6, *P<.05 by ANOVA and Dunnett test). Strong activation of mtNOS selectively occurs at half-maximal insulin dose.
###end p 73
###begin p 74
(0.17 MB EPS)
###end p 74
###begin p 75
Click here for additional data file.
###end p 75
###begin p 76
###xml 442 443 442 443 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 35 39 <span type="species:ncbi:10116">rats</span>
###xml 113 117 <span type="species:ncbi:10116">rats</span>
Effects of long-lasting insulin in rats. (A) A non-invasive hyperinsulinemic normoglycemic clamp was achieved in rats by subcutaneous administration of 0.1 U/Kg of insulin glargine and 5% oral sucrose ad libitum; after an initial peak, level of insulin+metabolites remains remarkably stable by 20 hours. (B). The rate of sucrose intake of animals with or without (C) insulin (white bar), at the same dose but at different times (dark bars); *P<.05 respect control by ANOVA and Dunnett test).
###end p 76
###begin p 77
(0.24 MB EPS)
###end p 77
###begin p 78
Click here for additional data file.
###end p 78
###begin p 79
###xml 40 43 <span type="species:ncbi:10116">rat</span>
Sequence of hairpin siRNAs designed for rat nNOS (gi: 16258810). siRNAs were cloned in vector pRNAT-U6.1/Neo with BamH I and Hind III restriction enzymes; in red, poly A tail. siRNA # 1 was preferentially used in the in vivo studies because of its maximal inhibitory effect.
###end p 79
###begin p 80
(0.33 MB EPS)
###end p 80
###begin p 81
Click here for additional data file.
###end p 81
###begin p 82
We are grateful to Dennis Stuehr (Ph.D) for providing us with cloned nNOS, to Daniel De Seta for insuline glargine and to Natalia Riobo (Ph.D) and Juan J. Gagliardino (Ph.D) for their helpful comments.
###end p 82
###begin title 83
References
###end title 83
###begin article-title 84
Nitric oxide and the control of firefly flashing.
###end article-title 84
###begin article-title 85
Regulation of oxygen metabolism by nitric oxide.
###end article-title 85
###begin article-title 86
Improving metabolism by increasing energy expenditure.
###end article-title 86
###begin article-title 87
Reactive oxygen species have a causal role in multiple forms of insulin resistance.
###end article-title 87
###begin article-title 88
###xml 70 78 <span type="species:ncbi:9606">patients</span>
Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes.
###end article-title 88
###begin article-title 89
Muscle glycogen content affects insulin-stimulated glucose transport and protein kinase B activity.
###end article-title 89
###begin article-title 90
Mitochondrial nitric oxide in the signaling of cell integrated responses.
###end article-title 90
###begin article-title 91
The regulation of mitochondrial oxygen uptake by redox reactions involving nitric oxide and ubiquinol.
###end article-title 91
###begin article-title 92
Regulation of mitochondrial respiration by nitric oxide inhibition of cytochrome c oxidase.
###end article-title 92
###begin article-title 93
Production of nitric oxide by mitochondria.
###end article-title 93
###begin article-title 94
Hypothyroid phenotype is contributed by mitochondrial complex I inactivation due to translocated neuronal nitric oxide synthase.
###end article-title 94
###begin article-title 95
Mitochondrial type I nitric oxide synthase physically interacts with cytochrome c oxidase.
###end article-title 95
###begin article-title 96
Identification of a neuronal nitric oxide synthase in isolated cardiac mitochondria using electrochemical detection.
###end article-title 96
###begin article-title 97
###xml 76 80 <span type="species:ncbi:10116">rats</span>
Modulation of mitochondrial nitric oxide synthase and energy expenditure in rats during cold acclimation.
###end article-title 97
###begin article-title 98
###xml 93 96 <span type="species:ncbi:10116">rat</span>
Mitochondrial nitric oxide synthase drives redox signals for proliferation and quiescence in rat liver development.
###end article-title 98
###begin article-title 99
###xml 69 72 <span type="species:ncbi:10116">rat</span>
Effect of sustained hypobaric hypoxia during maduration and aging on rat myocardium.II. mtNOS activity.
###end article-title 99
###begin article-title 100
The assumption that nitric oxide inhibits mitochondrial ATP synthesis is correct.
###end article-title 100
###begin article-title 101
###xml 60 64 <span type="species:ncbi:10090">mice</span>
Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKBbeta)
###end article-title 101
###begin article-title 102
Regulation of endothelium-derived nitric oxide production by the protein kinase Akt.
###end article-title 102
###begin article-title 103
Biochemistry of mitochondrial nitric oxide.
###end article-title 103
###begin article-title 104
Neuronal nitric oxide synthase mutant (Ser1412Asp) demonstrates surprising connections between heme reduction NO complex formation and catalysis.
###end article-title 104
###begin article-title 105
Rapid accumulation of Akt in mitochondria following phosphatidylinositol 3-kinase activation.
###end article-title 105
###begin article-title 106
SH2-containing Inositol Phosphatase 2 predominantly regulates Akt2, and not Akt1, phosphorylation at the plasma membrane in response to insulin in 3T3-L1 adipocytes.
###end article-title 106
###begin article-title 107
Biphasic coupling of neuronal nitric oxide synthase phosphorylation to the NMDA receptor regulates AMPA receptor trafficking and neuronal cell death.
###end article-title 107
###begin article-title 108
C-terminal Tail Residue Arg1400 enables NADPH to regulate electron transfer in neuronal nitric-oxide synthase
###end article-title 108
###begin article-title 109
###xml 49 54 <span type="species:ncbi:9606">human</span>
Characterization of testis-specific isoenzyme of human pyruvate dehydrogenase.
###end article-title 109
###begin article-title 110
Muscle glycogen and metabolic regulation.
###end article-title 110
###begin article-title 111
Insulin regulation of skeletal muscle PDK4 mRNA expression is impaired in acute insulin-resistant states.
###end article-title 111
###begin article-title 112
###xml 21 26 <span type="species:ncbi:9606">human</span>
Effect of insulin on human skeletal muscle mitochondrial ATP production, protein synthesis, and mRNA transcripts.
###end article-title 112
###begin article-title 113
Peroxisomal-mitochondrial oxidation in a rodent model of obesity-associated insulin resistance.
###end article-title 113
###begin article-title 114
###xml 75 79 <span type="species:ncbi:10090">mice</span>
Uric acid and anti-TNF antibody improve mitochondrial dysfunction in ob/ob mice.
###end article-title 114
###begin article-title 115
###xml 47 51 <span type="species:ncbi:10090">mice</span>
Mitochondrial nitric oxide is increased in the mice Ob-/- model of metabolic syndrome.
###end article-title 115
###begin article-title 116
Mitochondrial Dysfunction and Type 2 Diabetes.
###end article-title 116
###begin article-title 117
Muscle Mitochondrial ATP Synthesis and Glucose Transport/Phosphorylation in Type 2 Diabetes.
###end article-title 117
###begin article-title 118
###xml 87 90 <span type="species:ncbi:10116">rat</span>
Nitric oxide inhibits electron transfer and increases superoxide radical production in rat heart mitochondria and submitochondrial particles.
###end article-title 118
###begin article-title 119
Nitric oxide inhibits mitochondrial NADH : ubiquinone reductase activity through peroxynitrite formation.
###end article-title 119
###begin article-title 120
Mechanism of disease: endothelial dysfunction in insulin resistence and diabetes.
###end article-title 120
###begin article-title 121
###xml 61 66 <span type="species:ncbi:10090">mouse</span>
Protein tyrosine nitration in the mitochondria from diabetic mouse heart.
###end article-title 121
###begin article-title 122
S-nitrosylation-dependent inactivation of Akt/PKB in insulin resistanse.
###end article-title 122
###begin article-title 123
Nitric oxide-induced S-glutathionylation and inactivation of glyceraldehydes-3-phosphate dehydrogenase.
###end article-title 123
###begin article-title 124
Defective mitochondrial biogenesis. A hallmark of the high cardiovascular risk in the metabolic syndrome?
###end article-title 124
###begin article-title 125
Insulin glargine: a review of its therapeutic use as a long-acting agent for the management of type 1 and 2 diabetes mellitus.
###end article-title 125
###begin article-title 126
Insulin glargine: a new long-acting product.
###end article-title 126
###begin article-title 127
###xml 82 86 <span type="species:ncbi:10116">rats</span>
###xml 91 98 <span type="species:ncbi:9986">rabbits</span>
Evaluation of the reproductive toxicity and embryotoxicity of insulin Glargine in rats and rabbits.
###end article-title 127
###begin article-title 128
###xml 92 95 <span type="species:ncbi:10116">rat</span>
Composition and size of type II, IIA, IID/X and IIB fibers and citrate synthase activity of rat muscle.
###end article-title 128
###begin article-title 129
###xml 33 37 <span type="species:ncbi:10090">mice</span>
Inhibition of gene expression in mice muscle by in vivo electrically mediated siRNA delivery.
###end article-title 129
###begin article-title 130
Mechanism of protein import into mitochondria.
###end article-title 130
###begin article-title 131
###xml 130 134 <span type="species:ncbi:10090">mice</span>
Decreased basal, noninsulin-stimulated glucose uptake and metabolism by skeletal muscle isolated from obese-hyperglycemic (ob/ob) mice.
###end article-title 131
###begin article-title 132
Synthesis of glycogen from uridine diphosphate glucose in liver.
###end article-title 132
###begin p 133
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 133
###begin p 134
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was supported with research grants from the Agencia Nacional para la Promocion Cientifica Tecnologica (FONCYT; PICT 8468 and PICT 14199), Ubacyt M063 (University of Buenos Aires), CONICET (PIP 5495), Fundacion Perez Companc, Fundacion Florencio Fiorini, Fundacion Qualitas, and Asociacion Cooperadora del Hospital de Clinicas, Buenos Aires, Argentina.
###end p 134

